Assisted Reproductive Technology Market Size, Share, Opportunities, And Trends By Technique (In Vitro Fertilization (IVF), Artificial Insemination, Frozen Embryo Transfer, Others), By Procedure (Fresh Donor, Fresh Non-donor, Frozen Donor, Frozen Non-donor), By End-User (Hospitals, Fertility Clinics), And By Geography - Forecasts From 2023 To 2028

The assisted reproductive technology market is expected to grow at a CAGR of 8.32% from US$26.280 billion in 2021 to US$45.984 billion in 2028.

The word medical procedure used to cure infertility is assisted reproductive technology (ART). Fertility therapy is the term used when treatments are utilized to treat infertility. All forms of assisted reproductive technology (ART) include the handling of either eggs or embryos. ART methods often entail surgically extracting eggs from a woman's ovaries, fertilizing them in a lab, and either putting them back into her body or giving them to another woman.

Opportunities for the cryptococcosis market to increase

Throughout the anticipated period, assisted reproductive technology market growth is anticipated to be driven by increased disposable income, higher ART success rates, and higher infertility rates in emerging nations. According to World Health Organisation Statistics 2020, 186 million people worldwide experience infertility-related problems. The increased incidence of infertility can be attributed to a variety of factors, including STIs, an increase in smoking, obesity, endometriosis, polycystic ovary syndrome (PCOS), primary ovarian insufficiency (POC), and others.

Increasing prevalence of infertility among individuals

An increase in the use of assisted reproductive technology among women who are experiencing increased infertility as a result of factors like rising inactivity, which in turn causes obesity among women and several chronic diseases. It led to an increase in infertility and improved the assisted reproductive technology market, which saw an improved market growth rate over the anticipated period thanks to improved assisted reproductive technology-produced technologies.

Increasing ovulation disorders in women, increased menstrual problems, and hormonal imbalance in women may affect menstruation and ovulation, which helps to drive the assisted reproductive technology industry with rising consumer demands and rising integration of cutting-edge technologies in healthcare facilities.

Organizational initiatives to drive the market

Several groups, like the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology (SART), are working together to spread knowledge of the various infertility treatment options. CooperSurgicals, for instance, found that culture media containing Granulocyte-macrophage Colony-Stimulating Factor (GM-CSF) contains essential nutrients needed for embryo development and further enhances the transmission between the embryo and the endometrium, creating the necessary environment for the pregnancy. Further, India formally passed legislation governing surrogacy services in the nation in January 2022. In India, the two statutes seek to control IVF clinics and outlaw commercial surrogacy.

An increasing number of single-parenting

It is projected that the assisted reproductive technology market will grow considerably throughout the forecast period due to factors including the growing number of single parents, growing acceptance of same-sex relationships, and other developments. For instance, according to the Human Rights Campaign (HRC) Foundation's 2022 report, there are already 32 countries where same-sex marriage is legal, and more are projected to follow since parliamentary or legal processes are ongoing in several other nations.

Increasing public awareness about In-vitro Fertilization technology

Significant variables that are anticipated to have a significant impact on the development of the assisted reproductive technology industry are improvements in IVF technology, more public awareness of surrogacy and governmental restrictions on it, and increased insurance coverage for IVF. The most successful type of assisted reproductive technology is In-Vitro Fertilization (IVF). The process is possible with the use of the couple's sperm and eggs. A known or unknown donor's eggs, sperm, or embryos may also be used during IVF.

Enhancement in technology

Depending on the needs of the patient, several techniques are used, such as in vitro fertilization (IVF), artificial insemination, zygote intra-fallopian transfer (ZIFT), and gamete intra-fallopian transfer (GIFT). To prepare the body for ART, medications such as orals and injectable hormones are utilized both before and throughout the therapy. The pharmaceutical market is anticipated to expand rapidly with a complex pipeline. Additionally, INVOcell and Anecova have created in vivo ART products that are anticipated to support assisted reproductive technology market growth throughout the projection period.

The market for assisted reproductive technologies in Europe is expected to grow rapidly. 

As per the European Society of Human Reproduction and Embryology, 25 million people in Europe have a high prevalence of infertility which is anticipated to fuel the regional market. The forecast era is likely to see tremendous growth in North America due to factors like rising infertility in the region and initiatives by public organizations that are likely to increase assisted reproductive technology market growth over the forecast period, North America is expected to hold a significant market share in the global assisted reproductive technology market. Furthermore, the assisted reproductive technology market is anticipated to develop as a result of ART technology advances and the introduction of new products.

Market Key Developments

• In January 2023, With the signing of a distribution deal with Ming Mei Technology Co. Ltd., INVO Bioscience, a commercial-stage fertility firm well-known for its intravaginal culture process and INVOcell medical device, will now be able to serve the Taiwanese market.
• In June 2022, Inception Fertility released HavenCryo, a long-term reproductive tissue and cryopreservation storage solution that offers a unique experience for fertility experts and patients.
• In April 2022, Inception Fertility (Inception) and Oura, a wearable health platform, began a first-of-its-kind research study to track the biological changes that take place during the menstrual cycle.

Assisted Reproductive Technology Market Scope:

 

Report Metric	Details
Market Size Value in 2021	US$26.280 billion
Market Size Value in 2028	US$45.984 billion
Growth Rate	CAGR of 8.32% from 2021 to 2028
Base Year	2021
Forecast Period	2023 – 2028
Forecast Unit (Value)	USD Billion
Segments Covered	Technique, Procedure, End-User, and Geography
Regions Covered	North America, South America, Europe, Middle East and Africa, Asia Pacific
Companies Covered	Irvine Scientific, Merck Group, IMV Technologies, IVTech, Mayo Clinic, Wolters Kluwer, Hudson Institute of Medical Research, Rocky Mountain Fertility Center, GE Healthcare
Customization Scope	Free report customization with purchase

 

Segmentation:

• By Technique
  • In Vitro Fertilization (IVF)
  • Artificial Insemination
  • Frozen Embryo Transfer
  • Others
• By Procedure
  • Fresh Donor
  • Fresh Non-donor
  • Frozen Donor
  • Frozen Non-donor
• By End-User
  • Hospitals
  • Fertility Clinics
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Thailand
    • Others

---

1.  INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TECHNIQUE

5.1. Introduction

5.2. In Vitro Fertilization (IVF)

5.3. Artificial Insemination

5.4. Frozen Embryo Transfer

5.5. Others

6. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PROCEDURE

6.1. Introduction

6.2. Fresh Donor

6.3. Fresh Non-donor

6.4. Frozen Donor

6.5. Frozen Non-donor

7. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END-USER

7.1. Introduction

7.2. Hospitals

7.3. Fertility Clinics

8. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Spain

8.4.5. Others

8.5. The Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Israel

8.5.4. Others

8.6. Asia Pacific

8.6.1. Japan

8.6.2. China

8.6.3. India

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES 

10.1. Irvine Scientific

10.2. Merck Group

10.3. IMV Technologies

10.4. IVTech

10.5. Mayo Clinic

10.6. Wolters Kluwer

10.7. Hudson Institute of Medical Research

10.8. Rocky Mountain Fertility Center

10.9. GE Healthcare

Irvine Scientific

Merck Group

IMV Technologies

IVTech

Mayo Clinic

Wolters Kluwer

Hudson Institute of Medical Research

Rocky Mountain Fertility Center

GE Healthcare